Your browser doesn't support javascript.
loading
Conservative and Surgical Management of Spinal Cord Cavernous Malformations.
Ohnishi, Yu-Ichiro; Nakajima, Nobuhiko; Takenaka, Tomofumi; Fujiwara, Sho; Miura, Shinpei; Terada, Eisaku; Yamada, Shuhei; Kishima, Haruhiko.
Afiliación
  • Ohnishi YI; Department of Neurosurgery, Osaka University Medical School, Suita, Osaka, Japan.
  • Nakajima N; Department of Neurosurgery, Osaka University Medical School, Suita, Osaka, Japan.
  • Takenaka T; Department of Neurosurgery, Osaka University Medical School, Suita, Osaka, Japan.
  • Fujiwara S; Department of Neurosurgery, Osaka University Medical School, Suita, Osaka, Japan.
  • Miura S; Department of Neurosurgery, Osaka University Medical School, Suita, Osaka, Japan.
  • Terada E; Department of Neurosurgery, Osaka University Medical School, Suita, Osaka, Japan.
  • Yamada S; Department of Neurosurgery, Osaka University Medical School, Suita, Osaka, Japan.
  • Kishima H; Department of Neurosurgery, Osaka University Medical School, Suita, Osaka, Japan.
World Neurosurg X ; 5: 100066, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31891154
OBJECTIVES: We present a case series of spinal cord cavernous malformations (SCCMs) to describe clinical presentation and outcomes of both surgical and conservative management. METHODS: The clinical courses of patients diagnosed with SCCMs at our institution were retrospectively reviewed. Neurologic symptoms were evaluated using the Modified McCormick Scale. RESULTS: A total of 18 patients were identified. Five patients (27.8%) presented with acute onset bleeding, 4 of whom underwent immediate surgical resection. Thirteen patients (72.2%) were initially managed conservatively. Eight patients (38.9%) developed a hemorrhage during follow-up, and 8 (38.9%) required surgical resection due to bleeding or neurological worsening. The mean (range) duration from primary symptoms to subsequent hemorrhage or deterioration of symptoms was 1.42 (range: 0.25-4.33) years. The mean duration from primary symptoms to surgery was 2.10 (range: 0.25-5.0) years. No patients experienced subsequent hemorrhage after surgical resection. Eleven patients (84.6%) in the surgery group showed improved neurological status, and 2 patients (15.4%) remained unchanged. The annualized subsequent hemorrhage risk was 3.7%. Patients in the immediate surgical group had a significantly larger lesion compared with those in the conservative group. There was significance between the worst Modified McCormick Scale grades at the time of debilitating symptoms and the length of hemorrhage, but not the size of the lesion. CONCLUSIONS: Surgery for SCCMs resulted in no recurrence of hemorrhage or exacerbation of neurological symptoms, and should be considered for patients who experienced acute onset of hemorrhage or debilitating symptoms during follow-up.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: World Neurosurg X Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: World Neurosurg X Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos